FindTrial
Sign In

Use of green dye to early identify lymphedema in post-surgery breast cancer patients

Use of Indocyanine green (ICG) lymphography in early detection of lymphedema and response assessment of compression therapy following axillary dissection in breast cancer patients, a prospective interventional study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097651
Enrollment
100
Registered
2025-11-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C50- Malignant neoplasm of breast

Interventions

Intervention1: Indocyanine green dye (ICG): Use of Indocyanine green (ICG) dye to detect early lymphedema using lymphography Dose will be 0.3 ml of ICG solution (25mg mixed with 5ml of saline) Route o

Sponsors

Christian Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients undergoing surgery for carcinoma breast including axillary dissection or level one sampling or dissection

Exclusion criteria

Exclusion criteria: Age less than 18 years, having secondary edema due to another cause (not breast cancer related), iodine allergy, patient undergoing SLNB or recurrence following previous breast cancer surgery

Design outcomes

Primary

MeasureTime frame
Early detection of early(subclinical) lymphedema after breast cancer surgery using ICG lymphographyTimepoint: 3 to 6 months—

Secondary

MeasureTime frame
Identify patients having high risk of developing Lymphedema by the use of ICG lymphography pattern following breast cancer surgery. Institute early compression physiotherapy or intervention by lymphovenous anastomosis for treatment of lymphedema Assess the response to treatment using ICG lymphographyTimepoint: 6 to 12 months—

Countries

India

Contacts

Public ContactDr SURABHI SINGH

CHRISTIAN MEDICAL COLLEGE

supriyaspeedie@gmail.com8220148155

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026